← Browse by Condition
Medical Condition

kras mutation related tumors

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT05661201 Phase 1
Recruiting

NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors

Enrollment
24 pts
Location
United States
Sponsor
Georgetown University
View Trial →